Elevance Health, Inc. (ELV) is listed on NYSE in the Healthcare sector Β· Healthcare Plans industry. The current price is 415.12, up 2.29% from the previous close. Market cap is approximately $88B.
The commentary below is auto-generated by comparing market data (P/E, ROE, D/E, etc.) against predefined thresholds. No LLM is used. This is not a buy/sell recommendation from us or any analyst. For reference only.
Elevance Health, Inc. trades at a P/E of 17.82x, within the typical range for mature companies. Whether the multiple sits above or below the sector median is the cleaner relative-value read.
ELV's ROE of 11.13% is average. In this band, consistency and stability matter more than the absolute number.
ELV's D/E at 68.95 is on the high side. Credit rating, debt maturity ladder, and refinancing risk all become first-order considerations.
Revenue growth of 1.40% is in the single digits β a normal pace for mature businesses. Margin expansion and capital efficiency become the main EPS drivers.
Elevance Health, Inc.'s 1.70% yield is standard. If the company is also buying back stock, evaluate on total shareholder return (dividends + buybacks) rather than yield alone.
Demographic-driven structural demand growth is a long-running tailwind for healthcare.
Elevance Health, Inc. is near its 52-week high (436.24), in the top 13% of the range. Prices close to new highs invite two readings β little overhead supply, or stretched expectations β and volume is the usual tiebreaker.
Your watchlist and portfolio, one tap from your home screen β the Margin Call app
The day's high-to-low spread reached 3.25%, with a 2.29% move. Wide sessions frequently follow earnings, filings, or sector news, so identifying the catalyst matters.
Elevance Health, Inc. (ELV) is listed on NYSE, with recent volume of 304,642 shares. Volume is a supporting gauge of how much conviction sits behind a price move β the same gain reads differently on heavy versus light turnover.